IBD therapies designed with patients in mind.
Proud Supporter of World IBD Day
How common is IBD?
- An estimated 3.1 million adults (1.3%) in the United States have been diagnosed with inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis.
- New findings from a CDC study using data from the 2015 and 2016 National Health Interview Survey show that adults with IBD are more likely to have other chronic conditions than those without IBD.
- Because many chronic conditions are more common among adults with IBD, disease management might involve clinical care from several types of health care providers.
Available Therapies
Specific Biologic Therapies Available for IBD (Inflammatory Bowel Disease):
Managing IBD can be difficult, and we are here to help. We offer various treatment options, including intravenous therapy, injections, and infusion therapies.
Crohn’s Disease
- Cimzia® (certolizumab pegol)
- Entyvio® (vedolizumab)
- Remicade® (infliximab) + Biosimilars (Avsola®, Renflexis®)
- Stelara® (ustekinumab)
- Skyrizi® (risankizumab)
- Tysabri® (natalizumab)
Ulcerative Colitis
- Entyvio® (vedolizumab)
- Remicade® (infliximab) + Biosimilars (Avsola®, Renflexis®)
- Stelara® (ustekinumab)
Referring Patients
We encourage you to refer your IBD patients to Healix Infusion Care. We are confident that you will find Healix a valuable partner in their treatment journey.
How to Refer
Send us your infusion referrals, and we will take care of the rest. As the referring physician, your staff will get regular status updates from the Healix Infusion Care team.
Healthcare providers can use our referral forms to submit a patient order. Completed order forms and supporting clinicals can be faxed to (636) 614-2093 or uploaded to our secured portal.
We’ll handle everything else.
Questions? Give our team a call at (636) 385-5556. We’re happy to help!
Get Started with Healix Infusion Care
Use our locator to view the Healix Infusion Care Centers near you.